These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 35482831)

  • 21. New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication.
    Guignabert C; Tu L; Girerd B; Ricard N; Huertas A; Montani D; Humbert M
    Chest; 2015 Feb; 147(2):529-537. PubMed ID: 25644906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary arterial hypertension (ascites syndrome) in broilers: a review.
    Wideman RF; Rhoads DD; Erf GF; Anthony NB
    Poult Sci; 2013 Jan; 92(1):64-83. PubMed ID: 23243232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The transforming growth factor-beta/Smad2,3 signalling axis is impaired in experimental pulmonary hypertension.
    Zakrzewicz A; Kouri FM; Nejman B; Kwapiszewska G; Hecker M; Sandu R; Dony E; Seeger W; Schermuly RT; Eickelberg O; Morty RE
    Eur Respir J; 2007 Jun; 29(6):1094-104. PubMed ID: 17392319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages.
    Yaku A; Inagaki T; Asano R; Okazawa M; Mori H; Sato A; Hia F; Masaki T; Manabe Y; Ishibashi T; Vandenbon A; Nakatsuka Y; Akaki K; Yoshinaga M; Uehata T; Mino T; Morita S; Ishibashi-Ueda H; Morinobu A; Tsujimura T; Ogo T; Nakaoka Y; Takeuchi O
    Circulation; 2022 Sep; 146(13):1006-1022. PubMed ID: 35997026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune Cells in Pulmonary Arterial Hypertension.
    Ni S; Ji T; Dong J; Chen F; Feng H; Zhao H; Chen D; Ma W
    Heart Lung Circ; 2022 Jul; 31(7):934-943. PubMed ID: 35361533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic Approaches for Treating Pulmonary Arterial Hypertension by Correcting Imbalanced TGF-β Superfamily Signaling.
    Andre P; Joshi SR; Briscoe SD; Alexander MJ; Li G; Kumar R
    Front Med (Lausanne); 2021; 8():814222. PubMed ID: 35141256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivating the Uninhibited: The Tale of Activins and Inhibins in Pulmonary Arterial Hypertension.
    Ryanto GRT; Musthafa A; Hara T; Emoto N
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of TGF-β or BMPR2 signaling pathway-related miRNA in pulmonary arterial hypertension and systemic sclerosis.
    Xu B; Xu G; Yu Y; Lin J
    Arthritis Res Ther; 2021 Nov; 23(1):288. PubMed ID: 34819148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations.
    Guignabert C; Bailly S; Humbert M
    Expert Opin Ther Targets; 2017 Feb; 21(2):181-190. PubMed ID: 28001443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.
    Zhu N; Swietlik EM; Welch CL; Pauciulo MW; Hagen JJ; Zhou X; Guo Y; Karten J; Pandya D; Tilly T; Lutz KA; Martin JM; Treacy CM; Rosenzweig EB; Krishnan U; Coleman AW; Gonzaga-Jauregui C; Lawrie A; Trembath RC; Wilkins MR; ; ; ; ; Morrell NW; Shen Y; Gräf S; Nichols WC; Chung WK
    Genome Med; 2021 May; 13(1):80. PubMed ID: 33971972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory Antibodies against Activin A and TGF-β Reduce Self-Supported, but Not Soluble Factors-Induced Growth of Human Pulmonary Arterial Vascular Smooth Muscle Cells in Pulmonary Arterial Hypertension.
    Kudryashova TV; Shen Y; Pena A; Cronin E; Okorie E; Goncharov DA; Goncharova EA
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGFβ and BMPRII signalling pathways in the pathogenesis of pulmonary arterial hypertension.
    Tielemans B; Delcroix M; Belge C; Quarck R
    Drug Discov Today; 2019 Mar; 24(3):703-716. PubMed ID: 30529762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics and genomics of pulmonary arterial hypertension.
    Soubrier F; Chung WK; Machado R; Grünig E; Aldred M; Geraci M; Loyd JE; Elliott CG; Trembath RC; Newman JH; Humbert M
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D13-21. PubMed ID: 24355637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promising therapeutic approaches in pulmonary arterial hypertension.
    Ali MK; Ichimura K; Spiekerkoetter E
    Curr Opin Pharmacol; 2021 Aug; 59():127-139. PubMed ID: 34217109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
    Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR
    Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 37. Platelet-Derived TGF (Transforming Growth Factor)-β1 Enhances the Aerobic Glycolysis of Pulmonary Arterial Smooth Muscle Cells by PKM2 (Pyruvate Kinase Muscle Isoform 2) Upregulation.
    Zhu Y; Shu D; Gong X; Lu M; Feng Q; Zeng XB; Zhang H; Gao J; Guo YW; Liu L; Ma R; Zhu L; Hu Q; Ming ZY
    Hypertension; 2022 May; 79(5):932-945. PubMed ID: 35232222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activin-like kinase 5 (ALK5) mediates abnormal proliferation of vascular smooth muscle cells from patients with familial pulmonary arterial hypertension and is involved in the progression of experimental pulmonary arterial hypertension induced by monocrotaline.
    Thomas M; Docx C; Holmes AM; Beach S; Duggan N; England K; Leblanc C; Lebret C; Schindler F; Raza F; Walker C; Crosby A; Davies RJ; Morrell NW; Budd DC
    Am J Pathol; 2009 Feb; 174(2):380-9. PubMed ID: 19116361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole Exome Sequence Analysis Provides Novel Insights into the Genetic Framework of Childhood-Onset Pulmonary Arterial Hypertension.
    Gelinas SM; Benson CE; Khan MA; Berger RMF; Trembath RC; Machado RD; Southgate L
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33187088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension.
    Redel-Traub G; Sampson KJ; Kass RS; Bohnen MS
    Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.